FI934184A - Nya tiofen-2-karboxylsyraderivat och foerfarande foer framstaellning av dem - Google Patents

Nya tiofen-2-karboxylsyraderivat och foerfarande foer framstaellning av dem Download PDF

Info

Publication number
FI934184A
FI934184A FI934184A FI934184A FI934184A FI 934184 A FI934184 A FI 934184A FI 934184 A FI934184 A FI 934184A FI 934184 A FI934184 A FI 934184A FI 934184 A FI934184 A FI 934184A
Authority
FI
Finland
Prior art keywords
syraderating
nya
dem
thiophene
carboxyl
Prior art date
Application number
FI934184A
Other languages
English (en)
Other versions
FI934184A0 (fi
Inventor
Dieter Binder
Gerhard Greier
Original Assignee
Laevosan Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laevosan Gmbh & Co Kg filed Critical Laevosan Gmbh & Co Kg
Publication of FI934184A publication Critical patent/FI934184A/fi
Publication of FI934184A0 publication Critical patent/FI934184A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
  • Indicating Or Recording The Presence, Absence, Or Direction Of Movement (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI934184A 1991-04-04 1993-09-24 Nya tiofen-2-karboxylsyraderivat och foerfarande foer framstaellning av dem FI934184A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0071691A AT395425B (de) 1991-04-04 1991-04-04 Neue thiophen-2-carbonsaeurederivate und verfahren zu deren herstellung
PCT/AT1992/000044 WO1992017472A1 (de) 1991-04-04 1992-04-01 Neue thiophen-2-carbonsäurederivate und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
FI934184A true FI934184A (fi) 1993-09-24
FI934184A0 FI934184A0 (fi) 1993-09-24

Family

ID=3497929

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934184A FI934184A0 (fi) 1991-04-04 1993-09-24 Nya tiofen-2-karboxylsyraderivat och foerfarande foer framstaellning av dem

Country Status (15)

Country Link
US (1) US5352692A (fi)
EP (2) EP0507763A1 (fi)
JP (1) JPH06506208A (fi)
AT (2) AT395425B (fi)
AU (1) AU656772B2 (fi)
CA (1) CA2107662A1 (fi)
CZ (1) CZ280202B6 (fi)
DE (1) DE59208727D1 (fi)
DK (1) DK0581797T3 (fi)
ES (1) ES2104908T3 (fi)
FI (1) FI934184A0 (fi)
GR (1) GR3024594T3 (fi)
HU (1) HUT68476A (fi)
SK (1) SK106093A3 (fi)
WO (1) WO1992017472A1 (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000507593A (ja) * 1996-04-03 2000-06-20 メルク エンド カンパニー インコーポレーテッド ファルネシル―タンパク質トランスフェラーゼ阻害剤
US8208300B2 (en) * 2008-01-08 2012-06-26 Spansion Israel Ltd Non-volatile memory cell with injector

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2126597A1 (de) * 1971-05-28 1972-12-14 Farbwerke Hoechst AG, vormals, Meister Lucius & Brüning, 6000 Frankfurt Aminothiophencarbonsäureester und Verfahren zu ihrer Herstellung
GB2065121A (en) * 1979-12-13 1981-06-24 Pfizer Ltd Isoquinoline Derivatives
AT376436B (de) * 1982-11-05 1984-11-26 Laevosan Gmbh & Co Kg Verfahren zur herstellung neuer thiophen-2carbons[urederivate und pharmazeutisch vertraeglicher saeure- oder basenadditionssalze davon

Also Published As

Publication number Publication date
DE59208727D1 (de) 1997-09-04
CZ280202B6 (cs) 1995-11-15
ATE155783T1 (de) 1997-08-15
JPH06506208A (ja) 1994-07-14
EP0581797A1 (de) 1994-02-09
CZ9302002A3 (en) 1994-07-13
AU1640292A (en) 1992-11-02
SK106093A3 (en) 1994-08-10
AT395425B (de) 1992-12-28
GR3024594T3 (en) 1997-12-31
HU9302786D0 (en) 1993-12-28
CA2107662A1 (en) 1992-10-05
EP0507763A1 (de) 1992-10-07
WO1992017472A1 (de) 1992-10-15
ES2104908T3 (es) 1997-10-16
EP0581797B1 (de) 1997-07-23
DK0581797T3 (da) 1998-02-02
HUT68476A (en) 1995-06-28
ATA71691A (de) 1992-05-15
FI934184A0 (fi) 1993-09-24
AU656772B2 (en) 1995-02-16
US5352692A (en) 1994-10-04

Similar Documents

Publication Publication Date Title
DE69420068D1 (de) 1H-Indol-3-Acetamid-Derivate als sPLA2-Inhibitoren
ES2154622T3 (es) Derivados hidrofobos de taxano.
GR3004018T3 (fi)
HU910874D0 (en) 1,4,7,10-tetraaza-cyclododecane-butyl-thiol derivatives, process for producing these compounds and pharmaceutical preapratives containing them
AR247398A1 (es) Procedimiento para preparar compuestos de de 7-(2-(5-amino-1,2,4-tiadiazol-3- il)-2-alcoxiimino-acetamido)-3-metil-imidazopir idio o imidazopiridazinio-3 cefem-4-carboxilato
FI943508A0 (fi) Pyridiinikarboksimidamidiyhdisteet ja niiden käyttö
FI906408A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-aminopyrimidiini-4-karboksamidijohdannaisten valmistamiseksi
FI920349A (fi) Foerfarande foer framstaellning av nya tetrazolderivat och deras anvaendning.
FI103046B1 (fi) Menetelmä lääkeaineina käyttökelpoisten pyrrolidinyylitiokarbapeneemijohdannaisten valmistamiseksi
FI934184A (fi) Nya tiofen-2-karboxylsyraderivat och foerfarande foer framstaellning av dem
ES8304971A1 (es) Un procedimiento para la preparacion de derivados de tiocarbapenem 3-sustituidos.
FI94860C (fi) Menetelmä terapeuttisesti käyttökelpoisen (+)-1-/(3,4,5-trimetoksi)bentsyylioksimetyyli/-1-fenyyli-N,N-dimetyyli-n-propyyliamiinin valmistamiseksi
ES2108894T3 (es) Procedimiento para la preparacion de 5-cloroimidazoles eventualmente sustituidos en posicion 2.
AU536365B2 (en) Acetamidine derivatives
IE802690L (en) Substituted 2-phenylamino-imidazolines-(2)
DE59703279D1 (de) Herstellung eines Epoxids